NGM Biopharmaceuticals Financials

NGM Biopharmaceutica Stock Summary

NGM Biopharmaceutica competes with Instil Bio, Achilles Therapeutics, NextCure, Assembly Biosciences, and Erasca. NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California. Ngm Biopharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.

NGM Biopharmaceutica Key Financial Ratios

NGM Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NGM Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare NGM Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NGM Biopharmaceutica competition to find correlations between indicators driving NGM Biopharmaceutica's intrinsic value. More Info.NGM Biopharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value NGM Biopharmaceutica by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

NGM Biopharmaceutica Market Pulse

Along with financial statement analysis, the daily predictive indicators of NGM Biopharmaceutica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NGM Biopharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of NGM Biopharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing NGM Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NGM Biopharmaceutica's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.